InvestSMART

Artrya Limited (ASX: AYA) - Share Price

Current share price for AYA : $5.260 0.07 (1.31%)+

Artrya Limited (AYA), an ASX-listed company, is a company engaged in the development and commercialisation of a patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease.

AYA General Information +

ASX Code AYA
Website http://www.artrya.com
Industry/Sector Health Care Technology
Market Cap ($M) 856
AYA Share Price $5.260
Day High $5.480
Day Low $5.110
Last Close $5.330
AYA Share Price Movement $0.07 ( 1.31% )
Prices as at 13:06, 25 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Artrya Limited (AYA) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Artrya Limited (AYA) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Artrya Limited (AYA) price-sensitive announcements

AYA - March Quarterly Activities Report and Appendix 4C
Artrya Limited reported significant progress in the commercial roll-out of its Salix® AI-p
Artrya Limited (AYA)
30 Apr 2026 | 9:15 AM
AYA - Update - S&P DJI March 2026 Rebalance of the All Ordinaries
The S&P Dow Jones Indices announced the March 2026 quarterly rebalance of the All Ordinari
Artrya Limited (AYA)
10 Mar 2026 | 5:28 PM
AYA - S&P DJI Announces March 2026 Quarterly Rebalance
S&P Dow Jones Indices announced the March 2026 quarterly rebalance of the S&P/ASX indices,
Artrya Limited (AYA)
6 Mar 2026 | 5:05 PM
AYA - Appendix 4D and Interim Financial Report
Artrya Limited reported a substantial increase in net loss to $10.743 million for the half
Artrya Limited (AYA)
25 Feb 2026 | 7:58 PM

Artrya Limited (AYA) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Artrya Limited (AYA)
ORDINARY FULLY PAID
 Health Care $857 Change of Director's Interest Notice - B Ridgeway 18 Jun 2026 5:53PM $4.640 $5.260 risen by 13.36%
Artrya Limited (AYA)
ORDINARY FULLY PAID
 Health Care $857 Application for quotation of securities - AYA 18 Jun 2026 5:47PM $4.640 $5.260 risen by 13.36%
Artrya Limited (AYA)
ORDINARY FULLY PAID
 Health Care $857 Issue of Shares and Cleansing Notice 18 Jun 2026 5:42PM $4.640 $5.260 risen by 13.36%
Artrya Limited (AYA)
ORDINARY FULLY PAID
 Health Care $857 Change of Director Interests Notice 12 Jun 2026 9:58AM $4.700 $5.260 risen by 11.91%
Artrya Limited (AYA)
ORDINARY FULLY PAID
 Health Care $857 Sale of Shares to Fund Options Exercise 12 Jun 2026 9:58AM $4.700 $5.260 risen by 11.91%
Artrya Limited (AYA)
ORDINARY FULLY PAID
 Health Care $857 Application for quotation of securities - AYA 2 Jun 2026 5:16PM $4.680 $5.260 risen by 12.39%

AYA Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2027F C2 -$5.00 -50.00% 0.00 0.00 0.00% 0.0%
2026F C2 -$10.00 -43.70% 0.00 0.00 0.00% 0.0%
2025A -$16.41 -$17.80 -0.20% 0.00 0.00 0.00% 0.0%

AYA Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2025 A 2026 F 2027 F 2025 A 2026 F 2027 F 2025 A 2026 F 2027 F
4DMedical Limited (4DX) $2,816M 0.3304 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Artrya Limited (AYA) $841M -0.0017 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $18,066M 0.3919 0.2545 0.2962 157.0663 125.2027 96.5927 0.32% 0.41% 0.53%

AYA Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 28.40 0.00
Market 0.29 13.20 1.16 0.69
Sector 0.57 20.50 1.61 2.49

AYA Directors

Name Position Start Date
Mr Bernard (Bernie) William Ridgeway Non-Executive Chairman, Non-Executive Director 8 Feb 2021
Dr Jacque Sokolov Non-Executive Director 1 Aug 2022
Ms Catherine (Kate) Hill Non-Executive Director 22 Feb 2023
Dr Jeffrey LeBenger Non-Executive Director 18 Feb 2026

Artrya Limited (AYA) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
18 Jun 2026 RIDGEWAY, Bernard (Bernie) Exercise Options 750,000 $1.000 $750,000.000
18 Jun 2026 RIDGEWAY, Bernard (Bernie) Buy Indirect Shares 750,000 $1.000 $750,000.000
11 Jun 2026 RIDGEWAY, Bernard (Bernie) Sell Indirect Shares 300,000 $4.600 $1,380,000.000

See all changes in directors' interest & trades for Artrya Limited (AYA) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

AYA Management

Name Position
Mark Edward Pitts Company Secretary

AYA Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Artrya Limited (AYA). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
13,206,395 (8.91%) Regal Funds Management Pty Limited

AYA Calendar of Events

Date Event
24 February 2027 Report (Interim)
12 October 2026 Report (Annual)
19 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.